Back to the Top
The following message was posted to: PharmPK
Do you know if a dimer, that in vivo was bioconverted to the monomer
known product), could be considered a NCE. What sort of "new" studies
be mandatory for FDA submission? Toxicological ones?
Thank you in advance.
Jose Antonio Cordero
Ipsen Pharma S.A.
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (firstname.lastname@example.org)